UNIGE document Scientific Article
previous document  unige:94972  next document
add to browser collection

Synthesis of a selective HDAC6 inhibitor active in neuroblasts

Martinet, Nadine
Bertrand, Philippe
show hidden authors show all authors [1 - 9]
Published in Bioorganic & medicinal chemistry letters. 2016, vol. 26, no. 20, p. 4955-4959
Abstract In recent years, the role of HDAC6 in neurodegeneration has been partially elucidated, which led some authors to propose HDAC6 inhibitors as a therapeutic strategy to treat neurodegenerative diseases. In an effort to develop a selective HDAC6 inhibitor which can cross the blood brain barrier (BBB), a modified hydroxamate derivative (compound 3) was designed and synthetized. This compound was predicted to have potential for BBB penetration based on in silico and in vitro evaluation of passive permeability. When tested for its HDAC inhibitory activity, the IC50 value of compound 3 towards HDAC6 was in the nM range in both enzymatic and cell-based assays. Compound 3 showed a cell-based selectivity profile close to that of tubastatin A in SH-SY5Y human neuroblastoma cells, and a good BBB permeability profile.
PMID: 27650925
Full text
Article (Published version) (658 Kb) - document accessible for UNIGE members only Limited access to UNIGE
(ISO format)
ZWICK, Vincent et al. Synthesis of a selective HDAC6 inhibitor active in neuroblasts. In: Bioorganic & medicinal chemistry letters, 2016, vol. 26, n° 20, p. 4955-4959. doi: 10.1016/j.bmcl.2016.09.011 https://archive-ouverte.unige.ch/unige:94972

289 hits

0 download


Deposited on : 2017-06-20

Export document
Format :
Citation style :